Видео с ютуба Protalix News

Protalix Biotherapeutics (PLX) in an Enviable Position

Protalix to Develop More Plant-Cell Drugs, CEO Says

News Update: Protalix (PLX) Gets Prescription Drug User Fee Act Action Date for Taliglucerase

Protalix BioTherapeutics CEO on Biotechnology Breakthroughs

Protalix Fireside Chat. CEO Dror Bashan, CFO Eyal Rubin and Zacks Analyst John Vandermosten

INVESTOR NEWS || THIS STOCK HAS A PARABOLIC MOVE COMING || MUST WATCH

Protalix BioTherapeutics Q2 2025 Earnings Call